Drug intelligence / Profile preview

Perinez

Development stage
Unknown
Lead developer
Takeda
Modality
Recombinant Proteins and Enzymes
Administration
Intravenous
01

Overview

Perinez, also known by its brand name ADVATE or the Chinese name 百因止, is a recombinant human coagulation Factor VIII used for the treatment and prevention of bleeding in patients with Hemophilia A. Hemophilia A is a genetic bleeding disorder caused by a deficiency of Factor VIII, an essential blood clotting protein. Perinez works by replacing the missing Factor VIII, which acts as a cofactor for Factor IXa in the coagulation cascade, leading to the activation of Factor X and subsequent clot formation. It is a third-generation recombinant factor product, produced using gene recombination technology in Chinese hamster ovary cells, and is free from blood components, thereby reducing the risk of transmitting blood-borne pathogens.

Brand names
Perinez百因止ADVATE
Other names
Recombinant Human Coagulation Factor VIII for Injection注射用重组人凝血因子VIII
02

Targets

F8 (Coagulation Factor VIIIa)

Beyond the preview

Go deeper on Perinez.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Perinez.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call